Literature DB >> 26191186

MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.

Xiaoying Tian1, Limian Xu2, Peng Wang3.   

Abstract

Emerging evidence showed that miRNA dysregulation is involved in the development of endometriosis and may contribute to pathological process of endometriosis associated ovarian cancer (EAOC). miR-191 is one of the most differentially expressed miRNAs in pairwise comparisons among healthy controls, endometriosis, and EAOC patients. However, its regulative network in endometriosis and EAOC are still not clear. This study explored the role of miR-191 in TNF-α induced cell death in ovarian endometriosis and endometrioid carcinoma cells. Based on tissues samples collected from healthy controls, endometriosis, and EAOC patients, this study verified significantly higher expression of miR-191 in endometriosis and endometrioid cancer. Interestingly, we also observed inverse expression trend between miR-191 and DAPK1, a positive mediator of programmed cell death. By conducting luciferase assay, we confirmed miR-191 can directly target DAPK1 and regulate its expression. Functionally, we also found DAPK1 can promote TNF-α induced cell death. DAPK1 knockdown in endometriosis CRL-7566 cells can weaken its response to TNF-α induced cell death, while its overexpression in endometrioid cancer cells CRL-11731 enhanced the response. These functions of DAPK1 can be directly modulated by miR-191. Therefore, the miR-191-DAPK1 axis may play an important role modulating the response of ovarian endometriosis and endometrioid carcinoma cells to death-inducers and might contribute malignant transformation of endometriosis.

Entities:  

Keywords:  DAPK1; EAOC; endometriosis; miR-191

Mesh:

Substances:

Year:  2015        PMID: 26191186      PMCID: PMC4503058     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

2.  Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.

Authors:  Nabiha Missaoui; Sihem Hmissa; Amel Trabelsi; Cheick Traoré; Moncef Mokni; Robert Dante; Lucien Frappart
Journal:  Pathol Res Pract       Date:  2010-12-03       Impact factor: 3.250

3.  DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.

Authors:  Heon Jong Yoo; Hyun-Jung Byun; Boh-Ram Kim; Ki Hwan Lee; Sang-Yoon Park; Seung Bae Rho
Journal:  Cell Signal       Date:  2012-03-23       Impact factor: 4.315

4.  Novel genetic variants in miR-191 gene and familial ovarian cancer.

Authors:  Jie Shen; Richard DiCioccio; Kunle Odunsi; Shashikant B Lele; Hua Zhao
Journal:  BMC Cancer       Date:  2010-02-18       Impact factor: 4.430

5.  Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.

Authors:  Marilia F Calmon; Jucimara Colombo; Fabrício Carvalho; Fátima P Souza; José F G Filho; Erica E Fukuyama; Anamaria A Camargo; Otávia L S Caballero; Eloíza H Tajara; José A Cordeiro; Paula Rahal
Journal:  Cancer Genet Cytogenet       Date:  2007-02

6.  RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.

Authors:  Qiang Lin; Junfeng Geng; Kelong Ma; Jian Yu; Jinfeng Sun; Zhenya Shen; Guoliang Bao; Yinming Chen; Hongyu Zhang; Yinghua He; Xiaoying Luo; Xu Feng; Jingde Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-09       Impact factor: 4.553

7.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

8.  Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.

Authors:  Marcela G Del Carmen; Anne E Smith Sehdev; Amanda Nickles Fader; Marianna L Zahurak; Michael Richardson; John P Fruehauf; F J Montz; Robert E Bristow
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

Review 9.  miR-191: an emerging player in disease biology.

Authors:  Neha Nagpal; Ritu Kulshreshtha
Journal:  Front Genet       Date:  2014-04-23       Impact factor: 4.599

10.  Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.

Authors:  H S Kim; T H Kim; H H Chung; Y S Song
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more
  19 in total

1.  MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma.

Authors:  Peijie Chen; Xiang Pan; Liwen Zhao; Lu Jin; Canbin Lin; Jing Quan; Tao He; Liang Zhou; Xueling Wu; Yong Wang; Liangchao Ni; Shangqi Yang; Yongqing Lai
Journal:  Exp Ther Med       Date:  2017-11-28       Impact factor: 2.447

2.  MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis.

Authors:  Haiyan Hu; Huijuan Li; Yuanli He
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

Review 3.  MicroRNAs in endometriosis: biological function and emerging biomarker candidates†.

Authors:  Sarah Bjorkman; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-05-01       Impact factor: 4.285

4.  Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research.

Authors:  Peihao Fan; Nanyi Wang; Lirong Wang
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

Review 5.  Promising therapeutic targets of endometriosis obtained from microRNA studies.

Authors:  Kaei Nasu; Yoko Aoyagi; Ruofei Zhu; Mamiko Okamoto; Kentaro Kai; Yasushi Kawano
Journal:  Med Mol Morphol       Date:  2021-11-30       Impact factor: 2.309

Review 6.  The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.

Authors:  Xiyin Wang; Mircea Ivan; Shannon M Hawkins
Journal:  Gynecol Oncol       Date:  2017-08-31       Impact factor: 5.482

Review 7.  The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.

Authors:  Dipranjan Laha; Robert Grant; Prachi Mishra; Naris Nilubol
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

8.  Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma.

Authors:  Ying-Ying Kang; Yang Liu; Ming-Li Wang; Min Guo; Yan Wang; Zhi-Feng Cheng
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

9.  In silico model for miRNA-mediated regulatory network in cancer.

Authors:  Khandakar Tanvir Ahmed; Jiao Sun; William Chen; Irene Martinez; Sze Cheng; Wencai Zhang; Jeongsik Yong; Wei Zhang
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

10.  Dioscin induces demethylation of DAPK-1 and RASSF-1alpha genes via the antioxidant capacity, resulting in apoptosis of bladder cancer T24 cells.

Authors:  Qiang Zhou; Wie Song; Wei Xiao
Journal:  EXCLI J       Date:  2017-02-17       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.